Aktie A3C9E5 ACCUSTEM SCIENCES, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen AccuStem Sciences, Inc.

Aktien

A3C9E5

US00444A1016

ACUT

Markt geschlossen - OTC Markets
Andere Börsenplätze
 21:27:01 22.05.2024 		% 5 Tage % 1. Jan.
0,35 USD +11,09 % Intraday Chart für AccuStem Sciences, Inc. +26,35 % -44,06 %
20.05. AccuStem Sciences, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
22.03. AccuStem Sciences, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
AccuStem Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
AccuStem Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
AccuStem Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
AccuStem Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
AccuStem Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership
Accustem Sciences, Inc. and Emeritusdx Announce Joint Product Development Agreement and Strategic Partnership
AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers (form 8-K)
Accustem Sciences Inc. Announces Resignation of Jeff Fensterer as Chief Operating Officer, Effective as of June 16, 2023
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals
AccuStem Announce Strategic Clinical and Operational Partnership
Accustem Sciences Inc. Announces Strategic Clinical and Operational Partnership
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3C9E5 Aktie
  4. Nachrichten AccuStem Sciences, Inc.
  5. Andere Sprachen